Work

Outcomes of Scapular Osteosarcoma

Year: 2024

Type: article

Abstract: BACKGROUND/AIM: Scapular osteosarcoma is a rare malignancy, and the understanding of its optimal treatment strategies and long-term outcomes remains limited. The purpose of the current study was to evaluate our institutional experience. PATIENTS AND METHODS: We reviewed 14 patients (8 females, 5 males; mean age 44±17 years) treated for scapular osteosarcoma from 1985 to 2022. Tumors were confirmed histologically and treated with a multidisciplinary approach, including chemotherapy and surgery with a median follow-up of 10 years. RESULTS: Surgical complications occurred in eight patients, leading to repeat procedures in four. Complications were associated with the use of implants or allografts (p<0.01). Mean shoulder forward elevation and external rotation at follow-up were 42±61° and 12±16°, with a mean MSTS93 score of 61±19%. The 10-year disease-specific survival rates was 76%. Local recurrence was associated with worse survival (HR=13.19, p=0.04). CONCLUSION: Scapular osteosarcoma is rare, and with multidisciplinary management, local control is essential to patient survival.

Source: Anticancer Research

DOI: 10.21873/anticanres.17407